In adults w DM and cost related barriers consider use of lower cost medications for glycemic mgmt i e metformin SUs TZDs and human insulin w in the context of their risks for hypoglycemia wt gain CV and kidney events and other adverse effects E

In adults w/ DM and cost-related barriers, consider use of lower-cost medications for glycemic mgmt (i.e., metformin, SUs, TZDs, and human insulin) w/in the context of their risks for hypoglycemia, wt gain, CV and kidney events, and other adverse effects. [E]